Tivozanib in advanced inoperable hepatocellular carcinoma: considerations for patients with liver cirrhosis
- PMID: 33313275
- PMCID: PMC7729327
- DOI: 10.21037/atm-20-3526
Tivozanib in advanced inoperable hepatocellular carcinoma: considerations for patients with liver cirrhosis
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-3526). The authors have no conflicts of interests to declare.
Comment on
-
A multicentre phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma.Br J Cancer. 2020 Mar;122(7):963-970. doi: 10.1038/s41416-020-0737-6. Epub 2020 Feb 10. Br J Cancer. 2020. PMID: 32037403 Free PMC article. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources